Results 11 to 20 of about 224,178 (338)

Atopic dermatitis [PDF]

open access: yesAllergy, Asthma & Clinical Immunology, 2011
Atopic dermatitis (AD) is a common, chronic skin disorder that can significantly impact the quality of life of affected individuals as well as their families. Although the pathogenesis of the disorder is not completely understood, it appears to result from the complex interplay between defects in skin barrier function, environmental and infectious ...
Wade Watson, Sandeep Kapur
openaire   +6 more sources

Atopic and non-atopic eczema [PDF]

open access: yesBMJ, 2006
Atopic eczema is a chronic, relapsing, inflammatory skin condition associated with epidermal barrier dysfunction. This article provides a summary of current knowledge on eczema and its management. We used the following sources of information to write this review: Atopic eczema and atopic dermatitis are terms that have been used synonymously (for a ...
Brown, Sara, Reynolds, Nick J.
openaire   +4 more sources

Atopic Dermatitis [PDF]

open access: yesNew England Journal of Medicine, 2008
Atopic dermatitis (AD) is a chronic and relapsing disease affecting an increasing number of patients. Usually starting in early childhood, AD can be the initial step of the so-called atopic march, i.e. followed by allergic rhinitis and allergic asthma.
BUGGIANI, GIONATA   +2 more
openaire   +6 more sources

Atopic phenotypes and their implication in the atopic march

open access: yesExpert Review of Clinical Immunology, 2020
Eczema, allergic rhinitis, and asthma are traditionally considered atopic (or allergic) diseases. They are complex, multifactorial, and are caused by a variety of different mechanisms, which result in multiple heterogeneous clinical phenotypes. Atopic march is usually interpreted as the sequential development of symptoms from eczema in infancy, to ...
Custovic, A   +4 more
openaire   +6 more sources

ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children

open access: yesJournal of the European Academy of Dermatology and Venereology, 2020
Atopic dermatitis (AD) is a highly pruritic, chronic inflammatory skin disease. The diagnosis is made using evaluated clinical criteria. Disease activity and burden are best measured with a composite score, assessing both objective and subjective ...
A. Wollenberg   +27 more
semanticscholar   +1 more source

Exploring the effect of presence and type of allergen sensitization on fractional exhaled nitric oxide, immunoglobulin E, and interleukins 4, 5, and 13 among asthmatics

open access: yesLung India, 2020
Objective: Asthma is associated with airway inflammation. Allergen sensitization (atopy) is common in asthma. This study explored the effect of food and/or aeroallergen sensitization; on airway and systemic inflammation using fractional exhaled nitric ...
Nipun Malhotra, Nitesh Gupta, Raj Kumar
doaj   +1 more source

Diagnostic Features of Atopic Dermatitis

open access: yesActa Dermato-Venereologica, 1980
is missing.
J. Hanifin, G. Rajka
semanticscholar   +1 more source

Atopic dermatitis and the atopic march revisited [PDF]

open access: yesAllergy, 2013
AbstractAtopic dermatitis (AD) has become a significant public health problem because of increasing prevalence, together with increasing evidence that it may progress to other allergic phenotypes. While it is now acknowledged that AD commonly precedes other allergic diseases, a link termed ‘the atopic march’, debate continues as to whether this ...
Michael J. Abramson   +7 more
openaire   +3 more sources

Quality of Life of Allergic Dogs Treated with Allergen-Specific Immunotherapy—A Retrospective Study

open access: yesVeterinary Sciences, 2023
Background: The quality of life (QoL) of dogs with canine atopic dermatitis (CAD) treated with allergen-specific immunotherapy (ASIT) was studied to determine whether the QoL of dogs treated with ASIT (AG) improved compared with dogs not treated with ...
Tina Kotnik
doaj   +1 more source

Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.

open access: yesNew England Journal of Medicine, 2016
BACKGROUND Dupilumab, a human monoclonal antibody against interleukin-4 receptor alpha, inhibits signaling of interleukin-4 and interleukin-13, type 2 cytokines that may be important drivers of atopic or allergic diseases such as atopic dermatitis ...
E. Simpson   +24 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy